P

PainReform Ltd
D

PRFX

2.95000
USD
-0.25
(-7.81%)
Market Closed
Volume
2,426
EPS
-137
Div Yield
-
P/E
-0
Market Cap
1,642,008
News

Title: PainReform Ltd

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.